The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Open accessAbstract
Endolysins (or lysins) are highly evolved enzymes produced by bacteriophage (phage for short) to digest the bacterial cell wall for phage progeny release. In Gram-positive bacteria, small quantities of purified recombinant lysin added externally results in immediate lysis causing log-fold death of the target bacterium. Lysins have been used successfully in a variety of animal models to control pathogenic antibiotic-resistant bacteria found on mucosal surfaces and infected tissues. Their specificity for the pathogen without disturbing the normal flora, the low chance of bacterial resistance, and their ability to kill colonizing pathogens on mucosal surfaces, a capacity previously unavailable, make them ideal anti-infectives in an age of mounting resistance. Here we review the current literature showing the effectiveness of these enzymes in controlling a variety of infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984 · cited 1×
“be markedly reduced (Eiff et al., 2001; Hudson, 1994).”
BackgroundInsights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Holins: The Protein Clocks of Bacteriophage Infections
Wang, I.-N., Smith, D. L., & Young, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.799 · Cited by 806
Bacteriophage lysis: mechanism and regulation
Young, R. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.3.430-481.1992 · Cited by 773
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Self-citationNelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Self-citationBacteriophage endolysins — current state of research and applications
Loessner, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.002 · Cited by 537
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Self-citationPhages will out: strategies of host cell lysis
Young, R., Wang, I.-N., & Roof, W. D. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01705-4 · Cited by 433
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic
Brundage, J. F., & Shanks, G. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.071313 · Cited by 384
Loessner, M. J., Kramer, K., Ebel, F., & Scherer, S. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02889.x · Cited by 367
The Induction of Meningeal Inflammation by Components of the Pneumococcal Cell Wall
Tuomanen, E., Liu, H., Hengstler, B., Zak, O., & Tomasz, A. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.5.859 · Cited by 355
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
Self-citationCoello, R., Jiménez, J., García, M., Arroyo, P., Minguez, D., Fernández, C., Cruzet, F., & Gaspar, C. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026130 · Cited by 250
Kengatharan, K. M., De Kimpe, S., Robson, C., Foster, S. J., & Thiemermann, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.305 · Cited by 238
O'Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G. F., & Ross, R. P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.20.7161-7164.2005 · Cited by 234
Yoong, P., Schuch, R., Nelson, D., & Fischetti, V. A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4808-4812.2004 · Cited by 233
Self-citationCheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Self-citationRashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521305 · Cited by 232
O'Flaherty, S., Coffey, A., Edwards, R., Meaney, W., Fitzgerald, G. F., & Ross, R. P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.9.2862-2871.2004 · Cited by 231
Sass, P., & Bierbaum, G. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01616-06 · Cited by 222
Jado, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg485 · Cited by 216
PlyC: A multimeric bacteriophage lysin
Nelson, D., Schuch, R., Chahales, P., Zhu, S., & Fischetti, V. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604521103 · Cited by 207
Self-citationSurface Diffusion of Cellulases and Their Isolated Binding Domains on Cellulose
Jervis, E. J., Haynes, C. A., & Kilburn, D. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.24016 · Cited by 204
Multiple Enzymatic Activities of the Murein Hydrolase from Staphylococcal Phage φ11
Navarre, W. W., Ton-That, H., Faull, K. F., & Schneewind, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15847 · Cited by 180
Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages
García, P., García, J., García, E., Sánchez-Puelles, J., & López, R. (1990) · Gene · doi:10.1016/0378-1119(90)90116-9 · Cited by 175
Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages.
García, E., García, J. L., García, P., Arrarás, A., Sánchez-Puelles, J. M., & López, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.914 · Cited by 173
Hermoso, J. A., Monterroso, B., Albert, A., Galán, B., Ahrazem, O., Garcı́a, P., Martı́nez-Ripoll, M., Garcı́a, J. L., & Menéndez, M. (2003) · Structure · doi:10.1016/j.str.2003.09.005 · Cited by 171
Entenza, J. M., Loeffler, J. M., Grandgirard, D., Fischetti, V. A., & Moreillon, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4789-4792.2005 · Cited by 150
Self-citationLoessner, M. J., Maier, S. K., Daubek-Puza, H., Wendlinger, G., & Scherer, S. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.9.2845-2851.1997 · Cited by 148
A Protein Antibiotic in the Phage Qβ Virion: Diversity in Lysis Targets
Bernhardt, T. G., Wang, I., Struck, D. K., & Young, R. (2001) · Science · doi:10.1126/science.1058289 · Cited by 142
The Pneumococcal Cell Wall Degrading Enzymes: A Modular Design to Create New Lysins?
LÓPEZ, R., García, E., García, P., & García, J. L. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.199 · Cited by 142
Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes.
Dı́az, E., López, R., & García, J. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.8125 · Cited by 139
Hudson, I. (1994) · Journal of Hospital Infection · doi:10.1016/0195-6701(94)90001-9 · Cited by 139
Sizing the Holin Lesion with an Endolysin-β-Galactosidase Fusion
Wang, I., Deaton, J., & Young, R. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.779-787.2003 · Cited by 132
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia*
Witzenrath, M., Schmeck, B., Doehn, J. M., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819586a6 · Cited by 120
Walsh, S. M., Shah, A., & Mond, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.554-558.2003 · Cited by 117
Djurkovic, S., Loeffler, J. M., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1225-1228.2005 · Cited by 114
Self-citationNovel Strategy to Prevent Otitis Media Caused by Colonizing Streptococcus pneumoniae
McCullers, J. A., Karlström, Å., Iverson, A., Loeffler, J. M., & Fischetti, V. A. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030028 · Cited by 110
Self-citationPhage Lytic Enzyme Cpl‐1 for Antibacterial Therapy in Experimental Pneumococcal Meningitis
Grandgirard, D., Loeffler, J. M., Fischetti, V. A., & Leib, S. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587942 · Cited by 106
Self-citationde LENCASTRE, H., Kristinsson, K. G., Brito‐Avô, A., Santos‐Sanches, I., Sá‐Leão, R., Saldanha, J., Sigvaldadóttir, E., Karlsson, S. M., OLIVEIRA, D., Mato, R., et al. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.19 · Cited by 104
LambdaSa1 and LambdaSa2 Prophage Lysins of Streptococcus agalactiae
Pritchard, D. G., Dong, S., KIRK, M. C., Cartee, R. T., & Baker, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01783-07 · Cited by 90
Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus
Manoharadas, S., Witte, A., & Bläsi, U. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.09.003 · Cited by 81
Foley, S., Bruttin, A., & Brüssow, H. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.611-618.2000 · Cited by 73
Genomic Sequence of C 1 , the First Streptococcal Phage
Nelson, D. C., Schuch, R., Zhu, S., Tscherne, D. M., & Fischetti, V. A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.11.3325-3332.2003 · Cited by 57
Self-citationLópez, R., GarcÃa, J., GarcÃa, E., Ronda, C., & GarcÃa, P. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb14074.x · Cited by 49
Group A Streptococcus Carriage among Close Contacts of Patients with Invasive Infections
Weiss, K., Laverdière, M., Lovgren, M., Delorme, J., Poirier, L., & Béliveau, C. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009902 · Cited by 49
Brundage, J. F., & Shanks, G. D. (2007) · The Journal of Infectious Diseases · doi:10.1086/522355 · Cited by 46
Fernández‐López, M., Muñoz-Adelantado, E., Gillis, M., Willems, A. L., & Toro, N. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi144 · Cited by 27
Staphylococcal Bacteriophage-Associated Lysin: a Lytic Agent Active Against Staphylococcus aureus
Sonstein, S. A., Hammel, J. M., & Bondi, A. (1971) · Journal of Bacteriology · doi:10.1128/jb.107.2.499-504.1971 · Cited by 21
García, P., García, E., Ronda, C., Tomasz, A., & López, R. (1983) · Current Microbiology · doi:10.1007/bf01568846 · Cited by 20
Characterization of staphylococcal -lysin
Clyne, M., Birkbeck, T. H., & Arbuthnott, J. P. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-5-923 · Cited by 20
Introns in the Cytolethal Distending Toxin Gene ofActinobacillus actinomycetemcomitans
Tan, K. S., Ong, G., & Song, K. P. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.2.567-575.2005 · Cited by 14
Cited by
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
Escherichia coli in Europe: An Overview
Allocati, N., Masulli, M., Alexeyev, M., & Di Ilio, C. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126235 · Cited by 471
Genetically Engineered Phages: a Review of Advances over the Last Decade
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00069-15 · Cited by 427
Metadata
- Authors
- Fischetti, V. A.
- Venue
- International Journal of Medical Microbiology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 300
- Issue
- 6
- Pages
- 357-362
- ISSN
- 1438-4221 (ISSN-L)
- OpenAlex
- W2100402024
- Cited by
- 438
- References
- 54
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.